Virbac has launched Stelfonta, a novel injectable solution to treat mastocytoma in dogs.

Stelfonta is licensed for the treatment of non-resectable, non-metastatic (WHO staging¹) subcutaneous mast cell tumours (MCTs) located at or distal to the elbow or…

Virbac has launched a toolkit to help veterinary practices educate pet owners about the importance of checking their pet for abnormal lumps and bumps. 

The toolkit contains everything a practice needs to create its own lumps and bumps awareness campaign…

Virbac, maker of Stelfonta, has released the result of a quick poll of vets at the London Vet Show who said that on average, they had diagnosed 7.03 mast cell tumours (MCTs) in the last year, when earlier research had showed the figure should be more…